Websites Hosted in ns.uk.prserv.net Nameserver
The Nameserver ns.uk.prserv.net have a IP Address of 194.196.235.29 which is hosted on United Kingdom.
Astellas Pharma US | Changing Tomorrow | Home
Astellas Pharma brings brighter futures to patients, physicians, communities and employees as a new kind of pharmaceutical company
LafargeHolcim, global leader in building materials and solutions
Corporate website for LafargeHolcim, global leader in building materials and solutions. Including, product range, Investor, Media, HR and contact information.
Privat :: Wiener Städtische
Wiener Städtische Versicherung: der Marktführer bei Lebensversicherung und Pensionsvorsorge, Gesundheit- und Pflegeversicherung, Wohnen und Kfz-Versicherung, Reise- und...
Donau Versicherung AG Vienna Insurance Group
Donauversicherung
Overactive Bladder Medication | VESIcare® (solifenacin succinate)
VESIcare is used for the treatment of overactive bladder (OAB) with symptoms of urgency, frequency, and leakage.
AmBisome® | AmBisome (amphotericin B) liposome for injection
Learn about AmBisome (amphotericin B) liposome for injection and its side effects and prescribing information.
Overactive Bladder Medication | Myrbetriq (mirabegron)
Myrbetriq is an FDA-approved treatment for overactive bladder (OAB) with symptoms of urgency, frequency and leakage in adults. Learn about Myrbetriq.
MYCAMINE | MYCAMINE® (micafungin sodium)
Learn about MYCAMINE (micafungin sodium) and its side effects and prescribing information.
PROGRAF® (tacrolimus) | Twice-Daily Tacrolimus
PROGRAF is an anti-rejection medication for kidney, liver, or heart transplant patients. Please see complete Prescribing Information, including boxed warning.
Privat :: Wiener Städtische
Wiener Städtische Versicherung: der Marktführer bei Lebensversicherung und Pensionsvorsorge, Gesundheit- und Pflegeversicherung, Wohnen und Kfz-Versicherung, Reise- und...
Advanced Prostate Cancer Treatment | XTANDI® (enzalutamide)
XTANDI (enzalutamide) is a prescription medicine used to treat men with prostate cancer that no longer responds to a medical or surgical treatment that lowers testosterone and that has spread to other parts of the body.